Cancer Pharmacology Services

Offering a wide range of targeted oncology services and translational models. Our comprehensive platform includes:

• in vitro biochemical, biophysical, and cell-based assays, including
  • 600+ human cancer cell lines
  • 70+ PDX-derived cell lines
  • SPR, HTRF, ELISA, and FRET techniques

• ex vivo PD analysis, including:
  • histopathology services
  • NGS
  • Flow cytometry
  • Gene/protein expression analysis

• in vivo tumor models, including:
  • 320+ CDX and 1,400+ PDX models, covering 30 cancer types
  • 32 drug resistant models across 11 key targets
  • Transgenic mice covering 20+ targets
  • 20+ PBMC/HSC humanized models
  • 42 orthotopic models for 15 cancer types
  • 32 metastatic models across 7 cancer types
  • 88 syngeneic models covering 21 cancer types

View our extensive panel of translational oncology services